Incyte to Report 2009 Financial Results & 2010 Financial Guidance & Provide Update on Drug Discovery & Development Programs o...
February 09 2010 - 4:10PM
Business Wire
Incyte Corporation (Nasdaq: INCY) announced today that it has
scheduled its fourth quarter and year-end 2009 financial results
conference call for 8:30 a.m. ET on Thursday, February 18, 2010.
The schedules for the press release and conference call are as
follows:
- Q4 & YE 2009 Press Release:
February 18, 2010 at 7:00 a.m.
ET
- Q4 & YE 2009 Conference Call:
February 18, 2010 at 8:30 a.m.
ET
877-407-8037
- International Dial In Number:
201-689-8037
344827
If you are unable to participate, a replay of the conference
call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and dial-in number for international
callers is 201-612-7415. To access the replay you will need the
conference account number 278 and the ID number 344827.
The conference call will also be webcast live on CCBN and can be
accessed at www.incyte.com under Investor Relations, Events and
Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based drug
discovery and development company focused on developing proprietary
small molecule drugs for oncology, inflammation and diabetes.
Incyte’s most advanced compound, INCB18424, is in Phase III
development for myelofibrosis. For additional information on
Incyte, visit the Company's web site at www.incyte.com.
Incyte (NASDAQ:INCY)
Historical Stock Chart
From May 2024 to Jun 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jun 2023 to Jun 2024